| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5509993 | Clinical Biochemistry | 2017 | 7 Pages |
Abstract
NT-proBNP levels are elevated in patients with DTC, and are associated with an increased risk for cardiovascular events and all-cause mortality. Determination of NT-proBNP may identify DTC patients at increased cardiovascular risk, who could benefit from more stringent cardiovascular risk surveillance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Esther N. Klein Hesselink, Anouk N.A. van der Horst-Schrivers, Iwan C.C. van der Horst, Stephan J.L. Bakker, Anneke C. Muller Kobold, Adrienne H. Brouwers, Geertruida H. de Bock, Jourik A. Gietema, Robin P.F. Dullaart, Thera P. Links, Joop D. Lefrandt,